These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18261259)

  • 1. A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport?
    Borrione P; Parisi A; Salvo RA; Spaccamiglio A; Pautasso M; Baraban D; Piccoli GB; Pigozzi F; Angeli A
    J Biol Regul Homeost Agents; 2007; 21(3-4):79-88. PubMed ID: 18261259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
    Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
    Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-generation blood tests to detect erythropoietin abuse by athletes.
    Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
    Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of CD71, transferrin receptor, on immature reticulocytes in patients with paroxysmal nocturnal hemoglobinuria.
    Sato S; Kozuma Y; Hasegawa Y; Kojima H; Chiba S; Ninomiya H
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e137-43. PubMed ID: 19302232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biparametric flow cytometry analysis for the study of reticulocyte patterns of maturation.
    Borrione P; Spaccamiglio A; Parisi A; Salvo RA; Pautasso M; Pigozzi F; Angeli A
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):65-73. PubMed ID: 19196377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological definition of CD71 positive reticulocytes by various staining techniques and electron microscopy compared to reticulocytes detected by an automated hematology analyzer.
    Kono M; Kondo T; Takagi Y; Wada A; Fujimoto K
    Clin Chim Acta; 2009 Jun; 404(2):105-10. PubMed ID: 19302987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.
    Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Gargiullo E; Parisi A; Pigozzi F
    Blood Cells Mol Dis; 2001; 27(3):559-71. PubMed ID: 11355895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications and biomonitoring issues of recombinant erythropoietins for doping control.
    Tsitsimpikou C; Kouretas D; Tsarouhas K; Fitch K; Spandidos DA; Tsatsakis A
    Ther Drug Monit; 2011 Feb; 33(1):3-13. PubMed ID: 21099742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengths and weaknesses of established indirect models to detect recombinant human erythropoietin abuse on blood samples collected 48-hr post administration.
    Connes P; Caillaud C; Simar D; Villard S; Sicart MT; Audran M
    Haematologica; 2004 Jul; 89(7):891-2. PubMed ID: 15257956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of reference ranges in elite athletes for markers of altered erythropoiesis.
    Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Ashenden MJ; Gore CJ; Parisotto R; Hahn AG
    Haematologica; 2002 Dec; 87(12):1248-57. PubMed ID: 12495898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
    Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
    Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.
    Parisotto R; Wu M; Ashenden MJ; Emslie KR; Gore CJ; Howe C; Kazlauskas R; Sharpe K; Trout GJ; Xie M
    Haematologica; 2001 Feb; 86(2):128-37. PubMed ID: 11224480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of recombinant human erythropoietin in urine for doping analysis: interpretation of isoelectric profiles by discriminant analysis.
    Lasne F; Thioulouse J; Martin L; de Ceaurriz J
    Electrophoresis; 2007 Jun; 28(12):1875-81. PubMed ID: 17503402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
    Katodritou E; Terpos E; Zervas K; Speletas M; Kapetanos D; Kartsios C; Verrou E; Banti A; Effraimidou S; Christakis J
    Ann Hematol; 2007 May; 86(5):369-76. PubMed ID: 17375302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease.
    Harrod VL; Howard TA; Zimmerman SA; Dertinger SD; Ware RE
    Exp Hematol; 2007 Feb; 35(2):179-83. PubMed ID: 17258066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats.
    Wiczling P; Krzyzanski W; Zychlińska N; Lewandowski K; Kaliszan R
    Biopharm Drug Dispos; 2014 Sep; 35(6):330-40. PubMed ID: 24888906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood.
    Dertinger SD; Camphausen K; Macgregor JT; Bishop ME; Torous DK; Avlasevich S; Cairns S; Tometsko CR; Menard C; Muanza T; Chen Y; Miller RK; Cederbrant K; Sandelin K; Pontén I; Bolcsfoldi G
    Environ Mol Mutagen; 2004; 44(5):427-35. PubMed ID: 15517570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for recombinant human erythropoietin using [Hb], reticulocytes, the OFF(hr score), OFF(z score) and Hb(z score): status of the Blood Passport.
    Bornø A; Aachmann-Andersen NJ; Munch-Andersen T; Hulston CJ; Lundby C
    Eur J Appl Physiol; 2010 Jun; 109(3):537-43. PubMed ID: 20127125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.
    Ramakrishnan R; Cheung WK; Wacholtz MC; Minton N; Jusko WJ
    J Clin Pharmacol; 2004 Sep; 44(9):991-1002. PubMed ID: 15317827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.